Sign in

You're signed outSign in or to get full access.

Judy Krandel

Director at Beam GlobalBeam Global
Board

About Judy Krandel

Independent director at Beam Global since December 2023; age 60 as of August 25, 2025. She serves as Audit Committee Chair and is designated the Board’s “qualified financial expert,” with prior CFO and investment management experience; education includes a finance degree from Wharton and an MBA in finance and accounting from Chicago Booth .

Past Roles

OrganizationRoleTenureCommittees/Impact
Nephros, Inc. (NASDAQ: NEPH)Chief Financial OfficerCurrent (as of 2025)Public-company CFO; capital markets and investor relations expertise
Recruiter.com Group, Inc. (NASDAQ: RCRT)Chief Financial OfficerJun 2020–Sep 2023Public-company finance leadership
PeerStream, Inc.Chief Financial Officer; later Senior Business Development ConsultantNov 2016–Dec 2019Operating and BD roles at a tech company
Juniper Investment CompanyPortfolio Manager (small-cap hedge fund)Mar 2012–Nov 2016Investment management; capital allocation
Various firmsEquity analyst and portfolio manager (early career)Not specifiedSmall-cap public equities focus

External Roles

OrganizationRoleTenureNotes
Lincoln First BancorpDirector (past)Not disclosedPrior board service
Snap Interactive (NASDAQ: PALT)Director (past)Not disclosedPrior board service
CynergistekDirector (past)Not disclosedPrior board service (healthcare cybersecurity)

Board Governance

  • Committee assignments: Audit (Chair and financial expert), Compensation, Nominating & Governance, and Equity Oversight; all committees comprise independent directors under NASDAQ standards .
  • Independence: Board has four directors, three are independent per NASDAQ Capital Market criteria, with no family or vendor relationships; committee members (including Compensation and Nominating & Governance) are independent .
  • Attendance: In 2024, Board met 3 times; each director attended at least 75% of aggregate Board and committee meetings for their service period .
  • Leadership: CEO also serves as Chair; Board appointed Anthony Posawatz as Lead Independent Director; independent directors hold executive sessions at least annually .

Fixed Compensation

ComponentAmount/RatePeriodDetail
Base Board Retainer (cash)$15,000 per quarterPolicy (2024)Payable in arrears; continued service condition
Audit Chair fee (cash)$5,000 per quarterPolicy (2024)Additional to base retainer
Compensation Chair fee (cash)$3,750 per quarterPolicy (2024)Additional if chair (not applicable to Krandel)
Nominating & Governance Chair fee (cash)$2,500 per quarterPolicy (2024)Additional if chair (not applicable to Krandel)
Judy Krandel – 2024 Director CompensationAmount (USD)
Cash Fees Earned/Paid$80,000
Restricted Stock Awards (grant-date fair value)$125,000
Total$205,000

The $80,000 cash reflects $60,000 retainer + $20,000 Audit Chair fees based on the quarterly policy rates and her Audit Chair role , consistent with the reported total .

Performance Compensation

InstrumentGrant PolicyGrant TimingVesting2024 Amount
Restricted Common StockAnnual grant sized at $125,000 divided by prior month’s average daily closing price; rounded up to nearest 100 sharesJanuary each yearVests quarterly in four equal installments$125,000 grant-date fair value in 2024
OptionsNot disclosed for directorsN/AN/ANot listed in 2024 director compensation table
  • Notable filing event: Directors (including Krandel) filed late Form 4s for restricted stock awards granted on July 31, 2024, reported August 5, 2024 (administrative timeliness issue) .

Other Directorships & Interlocks

CompanyRoleInterlock/Considerations
Nephros, Inc. (NASDAQ: NEPH)CFOExecutive role at another public company; Board independence criteria note directors/officers do not serve at companies conducting vendor/service business with Beam, mitigating related-party risk
Snap Interactive (NASDAQ: PALT), Lincoln First Bancorp, CynergistekPast DirectorPrior board service; no Beam-related transactions disclosed

Expertise & Qualifications

  • Financial leadership and capital markets: CFO roles at multiple public companies; portfolio management experience; investor relations expertise .
  • Audit Committee “financial expert” per Item 407(d)(5)(ii), reinforcing oversight of reporting and controls .
  • Education: Wharton (finance); Chicago Booth MBA (finance, accounting) .

Equity Ownership

MetricValue
Total Beneficial Ownership (shares)61,442
Percent of Shares Outstanding* (less than 1%)
Unvested/Subject to Forfeiture (RSAs)20,226
Vested (derived: total minus unvested)41,216
Shares Outstanding Reference Date17,638,153 (as of Aug 25, 2025)
Pledging/HedgingNot disclosed in proxy

Insider Trades (Form 4 filings)

DateFormTransactionNotes
Aug 5, 2024 (reported)Late Form 4Restricted stock award granted Jul 31, 2024Reported late by directors including Judy Krandel
Dec 7, 2023 (reported)Form 4Restricted stock award granted Dec 4, 2023Initial grant following appointment

Governance Assessment

  • Strengths

    • Audit Committee chair and designated financial expert; breadth across all key committees increases oversight leverage .
    • Clear equity component in director pay; quarterly vesting promotes year-round engagement .
    • Independence affirmed under NASDAQ standards; Board utilizes a Lead Independent Director in a combined CEO/Chair structure .
  • Concerns / RED FLAGS

    • Late Section 16 filings for director equity grants (administrative compliance lapse) .
    • Combined CEO/Chair structure may concentrate power; mitigated by Lead Independent Director and independent committee chairs .
    • Concurrent CFO role at another public company raises time-commitment considerations; proxy independence criteria reduce related-party risk, but ongoing monitoring advisable .
  • Signals for investors

    • Compensation mix (cash + time-based restricted stock) aligns director incentives with equity value creation but lacks explicit performance metrics (e.g., TSR/EBITDA hurdles) for directors; oversight quality relies on committee rigor rather than pay-for-performance mechanics .
    • Ownership of 61,442 shares with 20,226 unvested suggests meaningful “skin-in-the-game” tied to continued service; position is under 1% of shares outstanding, typical for independent directors .